Risk factors for young premenopausal women with endometrial cancer.
about
Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancerPremenopausal abnormal uterine bleeding and risk of endometrial cancerEfficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.Therapeutically blocking Interleukin-11 Receptor-α enhances doxorubicin cytotoxicity in high grade type I endometrioid tumours.Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis.Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma.Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women.Clinic-based case-control study of the association between body mass index and endometrial cancer in Puerto Rican women.Endometrial adenocarcinoma in a 27-year-old woman.Characteristics and prognosis of coexisting adnexa malignancy with endometrial cancer: a single institution review of 51 cases.Hysteroscopic surgery for conservative management in endometrial cancer: a review of the literature.Synchronous gynecologic malignancy and preliminary results of Lynch syndromeEndometrial cancer after endometrial ablation vs medical management of abnormal uterine bleedingEndometrial tubal metaplasia in a young puerperal woman after breast cancerEndometrial and ovarian cancer in lynch syndrome.Fertility-conservation combined therapy with hysteroscopic resection and oral progesterone for local early stage endometrial carcinoma in young womenSynchronous and metachronous malignancy in endometrial cancer patients treated in a tertiary care center of Thailand.Leptin and cancer.Fertility-sparing therapy for young women with endometrial cancer.Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study.Fertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: Is it effective?Circulatory estrogen level protects against breast cancer in obese women.Fibulin-5 localisation in human endometrial cancer shifts from epithelial to stromal with increasing tumour grade, and silencing promotes endometrial epithelial cancer cell proliferation.Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.Premenopausal early-stage endometrial carcinoma patients with low CA-125 levels and low tumor grade may undergo ovary-saving surgery.Understanding Molecular Landscape of Endometrial Cancer through Next Generation Sequencing: What We Have Learned so Far?Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system.Accuracy of transvaginal ultrasonography compared to endometrial biopsy for the etiological diagnosis of abnormal perimenopausal bleeding.Synchronous tumours of the female genital tract.Oncological repercussions of polycystic ovary syndrome.Histopathological findings of endometrial specimens in abnormal uterine bleeding.Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods.Endometrioid endometrial adenocarcinoma: an increase of G3 cancers?Risk Factors for Endometrial Cancer: Results from a Hospital-Based Case-Control StudyLoss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia.Development of an integrated support system for hereditary cancer and its impact on gynecologic services.Fertility Preserved Hysteroscopic Approach for the Treatment of Stage Ia Endometrioid Carcinoma.Long-term outcomes after progestogen treatment for early endometrial cancer.Abnormal mismatch repair and other clinicopathologic predictors of poor response to progestin treatment in young women with endometrial complex atypical hyperplasia and well-differentiated endometrial adenocarcinoma: a consecutive case series.
P2860
Q28083257-AEEF5CE8-CAC0-4C08-8CD1-9C13A4E4F746Q30244243-A33E9416-2032-46D3-95C5-8FC78A543DC1Q30576718-274A10A4-DE76-4815-8639-476D321D8848Q33618450-59E7CE4A-9540-4703-A623-AEDDCB317EE0Q33804513-8749EF57-30E5-4488-85B3-9A8241CCEB83Q33918399-17497091-BD38-49AC-9FA6-E5F7603F14CAQ34140562-46C14A22-FD2A-4EAF-A88A-D278AA9B6F49Q34580098-F075F66F-D696-4549-B374-658C7F389843Q34611371-A7192A5C-4831-43DD-B0AE-4593C92696B8Q34852537-9665EC73-FE7F-4CD4-854B-A3E45BA55BC5Q35106159-ABCBEEAF-E8FB-4937-80B8-CF7F58BF108BQ35663630-D1A58579-C124-4C30-AF18-8E2A83FB426EQ35752387-71371BA7-85BF-4B68-AEF9-7FB2508D3F32Q35919589-857BB7BA-91D0-476F-BA08-65D846DC1F65Q36178261-B3C1DF4A-D75B-44DF-B88A-6A0A3C61956EQ36183292-9B97999B-C07D-458B-9295-5357DD9AA466Q36205603-8982374A-378E-408D-B6C6-EA2B5CC5A9AAQ36234841-31387D7E-FC35-4A83-AF1F-5FB5B98868FDQ36352064-CA94675A-C030-4425-85BB-8E08ABDF57C0Q36389906-F6162359-487D-4CA4-B54E-3CAE93C1587AQ36547575-581BEF22-31CE-47CA-9AFA-54541A086D24Q36795622-ACD581C2-2209-4301-8794-1D114547225CQ37002672-D72C49D8-178D-4467-8677-E2D2258E1436Q37199883-619471A3-23B1-4812-8086-6166260C79D1Q37376650-70E0293C-897A-4B9A-9ED9-4E66AE78C013Q37382351-B3AB6B06-DE65-4B82-A79A-5B8C4D45491FQ37512337-3F2FB156-7F19-448A-B335-41707F03C24AQ37638877-D7F8D2D1-EBB8-443C-809C-DA33A2B3B7E6Q37748898-FD1AE8D3-F4A9-4201-96EC-2EF7A0F4E430Q37763092-09F616D0-C7F8-4BEA-BD9D-AB5B38597CEEQ38152231-A796D2A7-3C72-4FC8-ACF2-A630F753667FQ38513642-D2D2F46D-565A-4AAE-A7A4-2D70267AA756Q38831227-D0D8ECB1-E216-46DD-976A-B5DD8F6E263DQ39136665-09B73CEA-E1F8-4C32-BC73-25B04B79D41BQ39967050-BCA80B95-EFB3-4FE9-9691-750A8CAEC1C2Q41654195-BF601BBF-DC11-4DFD-B358-E9E1F633369FQ43749121-64E3C2E4-F4A7-4219-ACD3-7030E5FD44E5Q44531241-BD61236B-9549-4CED-A4CC-BDDBFF60C8D1Q44627018-B56372B6-45F2-488E-972A-A9CE66BF3DC6Q46445529-A16CCDAA-AA7A-416E-87E3-CC4A83AD2691
P2860
Risk factors for young premenopausal women with endometrial cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Risk factors for young premenopausal women with endometrial cancer.
@ast
Risk factors for young premenopausal women with endometrial cancer.
@en
type
label
Risk factors for young premenopausal women with endometrial cancer.
@ast
Risk factors for young premenopausal women with endometrial cancer.
@en
prefLabel
Risk factors for young premenopausal women with endometrial cancer.
@ast
Risk factors for young premenopausal women with endometrial cancer.
@en
P2093
P1476
Risk factors for young premenopausal women with endometrial cancer.
@en
P2093
Brian M Slomovitz
Charlotte C Sun
David M Gershenson
Jonathan C Oh
Karen H Lu
Kathleen M Schmeler
Pamela T Soliman
Thomas W Burke
P304
P356
10.1097/01.AOG.0000154151.14516.F7
P407
P577
2005-03-01T00:00:00Z